Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy. Mersali S, Chapelle R, Ribeiro M, Weiss N, et al. Neurology 2026;107:e218561.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mersali S, Chapelle R, Ribeiro M, Weiss N, et al. Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy. Neurology 2026;107:e218561.
PMID: 42826379